Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML
Clinical trial NCT05569512 · TERMINATED
Trial details
- NCT number
- NCT05569512
- Sponsor
- Malika Kapadia
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-06
- Primary completion
- 2023-10-05
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.